What is the size of the CAR-T Cell Therapies market in 2023?

The CAR-T Cell Therapies market size is USD 2.8 billion in 2023.

What is the projected CAGR at which the CAR-T Cell Therapies market is expected to grow at?

The CAR-T Cell Therapies market is expected to grow at a CAGR of 13.8% (2024-2033).

List the key industry players of the CAR-T Cell Therapies market?

Juno Therapeutics Inc., Bristol-Myers Squibb Company, Bluebird Bio Inc., Gilead Sciences Inc., Merck & Co. Inc., Pfizer Inc., Sorrento Therapeutics Inc., Merck KGaA, Amgen Inc., Eureka Therapeutics Inc., Calyxt Inc., Autolus Therapeutics, CARsgen Therapeutics Co.Ltd., Poseida Therapeutics Inc., Fortress Biotech Inc.

Which region is more appealing for vendors employed in the CAR-T Cell Therapies market?

North America is expected to account for the highest revenue share of 61.49% and boasting an impressive market value of USD 1.8 billion. Therefore, the CAR-T Cell Therapies industry in North America is expected to garner significant business opportunities over the forecast period.

Name the key areas of business for CAR-T Cell Therapies?

The US, Canada, India, China, UK, Japan, & Germany are key areas of operation for the CAR-T Cell Therapies Market.

Global CAR-T Cell Therapies Market By Drug Type (Axicabtagene Cilolecucel, Tisagenlecleucel, Brezucabtagene Autoleucel, Brexucabtagene Autoleucel, Lisocabtagene Maraleucel), By Modality (Research and Commercialized), By Target Antigen (CD19, CD22, BCMA, and Others), By Indication, By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2033

Published date: Feb 2023
Report ID: 105628
Number of Pages: 310
Format:

- Juno Therapeutics, Inc.
- Bristol-Myers Squibb Company
- Bluebird Bio, Inc.
- Gilead Sciences, Inc.
- Merck & Co., Inc.
- Pfizer, Inc.
- Sorrento Therapeutics, Inc.
- Merck KGaA Company Profile
- Amgen Inc.
- Eureka Therapeutics Inc.
- Calyxt Inc.
- Autolus Therapeutics
- CARsgen Therapeutics Co.Ltd.
- Poseida Therapeutics, Inc.
- Fortress Biotech, Inc.
- Other Key Players
Settings

Related Reports

Our Clients

Inquiry Before Buying

Report ID 105628
Published Date Feb 2023
Rating
- ★★★★★
  
  ★★★★★
- (46)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible

	Single User $6,000 $3,999 USD / per unit save 24%	Multi User $8,000 $5,999 USD / per unit save 28%	Corporate User $10,000 $6,999 USD / per unit save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization	No	up to 10 hrs work	up to 30 hrs work
Accessibility	1 User	2-5 User	Unlimited
Analyst Support	up to 20 hrs	up to 40 hrs	up to 50 hrs
Benefit	Up to 20% off on next purchase	Up to 25% off on next purchase	Up to 30% off on next purchase
	Buy Now ($ 3,999)	Buy Now ($ 5,999)	Buy Now ($ 6,999)